Sania Therapeutics

Targeted, controllable gene therapies to redefine the treatment of nervous system disorders.

Surgeon analysing brain scans

Sania Therapeutics (pronounced 'sah-nee-ah') is a ground-breaking biotechnology company pioneering new approaches for targeted and controllable gene therapies to treat prevalent disorders. 

Sania’s approach harnesses neural circuits as a gateway to disease states. Their research and development is centred around a human-first approach to ultimately build more translatable, safer and cost-effective AAV gene therapies capable of treating millions of patients. 

The company is based in London. 

The Sania journey so far:

  • 2022: Sania was founded 
     
Caitriona O'Rourke

Dr Caitriona O'Rourke (Away from office)

Senior Business Manager

Dr O'Rourke has worked as a research associate on tissue engineering, drug delivery, regenerative medicine and stem cell biology. Her PhD looked at tissue engineering and her MSc in neuropharmacology.